Study guide

9.2 ICMJE Authorship Criteria and Qualification Scenarios

Certified Medical Publication Professional CMPP

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Preparation Strategy

1.1 ISMPP CMPP Certification Overview, Eligibility & Exam Format 1.2 Recertification, Continuing Education (CE) Credits & ISMPP U 1.3 Core Reference Hierarchy, Primary Documents & Test-Taking Strategy

2 Chapter 2: Publication Planning: Strategy, Environment & Scientific Platform

2.1 Medical Publication Lifecycle & Strategic Planning Frameworks 2.2 Therapeutic Landscape Analysis, Unmet Needs & Gap Analysis 2.3 Scientific Communication Platforms and Evidence-Based Language

3 Chapter 3: Publication Planning: Governance, Steering Committees & Venue Selection

3.1 Publication Steering Committees: Charters, Roles & Scientific Governance 3.2 Target Audience Identification: HCPs, Patients, Payers & Regulators 3.3 Venue Selection, Open Access, and Congress Strategy

4 Chapter 4: Publication Planning: Operations, Contracting, Global Alignment & Compliance

4.1 Publication Agreements, Review Rights, Compensation & Disclosure 4.2 Milestones, Gantt Charts, Budgeting & Vendor/Agency Management 4.3 Global vs. Regional/Local Publication Alignment & Localization 4.4 Publication SOPs, Documentation, Quality Control & Audit Readiness

5 Chapter 5: Reporting Guidelines: Foundational Standards & Trial Reporting

5.1 EQUATOR and Design-Specific Reporting Guidelines 5.2 CONSORT 2025 & Flow Diagrams for Randomized Trials 5.3 SPIRIT 2025: Standard Protocol Items for Interventional Trials

6 Chapter 6: Reporting Guidelines: Observational, Reviews & Preclinical

6.1 PRISMA 2020 for Systematic Reviews & Meta-Analyses 6.2 STROBE & RECORD for Observational and Routinely Collected Data 6.3 ARRIVE 2.0 for In Vivo Animal Research

7 Chapter 7: Specialized Reporting, Plain Language Summaries & Congress Submissions

7.1 STARD 2015, CARE, and Specialized Reporting Guidelines 7.2 Plain-Language Summaries and Patient Partnership 7.3 GPCAP 2026: Congress Abstracts, Presentations & Encores 7.4 Digital Publication Features, Accessibility, and Social Dissemination

8 Chapter 8: Manuscript Lifecycle: Drafting, Peer Review, Open Access & Metrics

8.1 Manuscript Development, Author Review, and Sponsor Boundaries 8.2 Peer Review, Rebuttals, Revisions, and Appeals 8.3 Preprints, Creative Commons & Current Open-Access Requirements 8.4 Post-Publication Metrics and Correcting the Record

9 Chapter 9: Ethical Principles: GPP 2022, Authorship Criteria & Contributorship

9.1 Good Publication Practice 2022: Principles, Scope & Application 9.2 ICMJE Authorship Criteria and Qualification Scenarios 9.3 Nonauthor Contributors, Acknowledgments, and CRediT

10 Chapter 10: Ethics & Transparency: Ghostwriting, Writing Assistance, COI & Disclosure

10.1 Ghostwriting, Guest Authorship, and Authorship Disputes 10.2 Professional Medical Writing: Roles, Authorship, Disclosure & Funding 10.3 Disclosure of Interests and Publication Transparency 10.4 Open Payments, EFPIA Codes & Publication-Related Transfers of Value

11 Chapter 11: Compliance & Legal: Clinical Trial Registration, Data Sharing, Regulatory & Ethics

11.1 Trial Registration and Results Disclosure: US, EU, and ICMJE 11.2 Clinical-Trial Data-Sharing Statements and FAIR Principles 11.3 FDA SIUU Guidance & Promotional/Scientific Communication Boundaries 11.4 2024 Declaration of Helsinki, Ethics Review, Privacy & Copyright

9.2 ICMJE Authorship Criteria and Qualification Scenarios

Key Takeaways Explain This Topic AI

ICMJE authorship requires all four criteria: qualifying contribution; drafting or critical intellectual revision; final approval; and accountability.

Contributors who meet the first criterion should be offered the opportunity to participate enough to meet criteria 2 through 4; authorship should not be denied by preventing that opportunity.

Funding, general supervision, administrative support, technical editing, or recruitment alone does not establish authorship, though the actual contribution may merit acknowledgment or a contributor statement.

Authorship order is decided collectively by the author group and varies by field; ICMJE does not assign universal meanings to first, last, or corresponding positions.

Final approval cannot be inferred from silence or supplied by a coordinator; unavailable contributors and byline changes require documentation and the journal’s process.

Last updated: October 2026

ICMJE Authorship Criteria and Qualification Scenarios

Authorship joins credit with public responsibility. The ICMJE framework is designed to ensure that every person on the byline made an appropriate contribution, participated in the manuscript, approved it, and can help answer questions about the work.

The four criteria

An author should satisfy all four:

Substantial contribution to conception or design; or acquisition, analysis, or interpretation of data.

Drafting or critical revision for important intellectual content.

Final approval of the version to be published.

Accountability for all aspects of the work, including helping ensure questions about accuracy or integrity are appropriately investigated and resolved.

The criteria are conjunctive, but they should not be weaponized. ICMJE says people who meet the first criterion should have the opportunity to participate in review, drafting, and final approval so they can potentially qualify. A team should not use a late invitation or impossible deadline to exclude a legitimate contributor.

What does not qualify by itself

Acquiring funding, providing general supervision, supplying laboratory space, offering administrative support, editing language, or recruiting participants alone does not satisfy all four criteria. These activities can still be important and may be recognized in a contributor statement or acknowledgment under journal policy and with permission.

Employment by a sponsor neither creates nor defeats authorship. A sponsor employee who meets all four criteria may qualify. An external investigator with prestige or high enrollment who does not meet all four does not. Reasonable payment for legitimate work also does not determine the byline; payment for a name or influence is unacceptable.

Apply Criterion 1 with judgment

“Substantial” is contextual. Acquisition of data can satisfy Criterion 1 when the contribution is substantial, but a numeric recruitment threshold alone is not enough. Interpretation is more than receiving a results deck; it involves meaningful intellectual engagement. Contribution taxonomies can document roles, but a CRediT label does not automatically establish ICMJE authorship.

A professional writer who drafts under author direction may or may not meet Criterion 1, depending on the total intellectual contribution. If the writer meets all four, consider authorship. Otherwise, disclose writing support transparently.

Criteria 2 through 4

Critical revision should address important intellectual content, not only punctuation or formatting. Final approval applies to the version to be published, including material revisions after peer review. A coordinator cannot approve for an author, and silence is not approval.

Accountability does not mean every author personally performed every analysis. Authors should know which coauthors are responsible for particular components and have confidence in the integrity of those contributions. If concerns arise, each author has a duty to cooperate in resolution rather than disown the work.

Author order and corresponding authors

The author group, not ICMJE, determines order. Conventions vary by discipline, culture, and journal. First author may indicate a leading contribution in many fields, and last author may indicate senior leadership in some, but these are not universal rules. Joint first or senior authorship depends on journal policy and should not obscure actual contributions.

The corresponding author manages communication with the journal and ensures administrative requirements are completed. That role does not confer ownership of the data or unilateral authority to add or remove authors.

Discuss order early and revisit it when contributions change. Record the rationale and resolve disagreements through the group or institution. Editors generally do not adjudicate contribution disputes.

Group authorship

Large collaborations may use a group name, named authors, and a contributor appendix. The journal's indexing and authorship rules control. Identify which individuals accept direct responsibility as authors and list other contributors accurately. A large consortium does not eliminate final approval and accountability requirements for the people presented as authors.

Unresponsive or departed contributors

If a contributor who met Criterion 1 does not participate in drafting or critical revision and cannot approve the final version, the person does not yet meet all four criteria. Make reasonable, documented contact attempts and offer a genuine opportunity to qualify. If the person remains unavailable, consult the journal.

Do not forge approval, list the person anyway, or silently remove a previously named author. Nonauthor recognition may be appropriate for the actual contribution, but obtain the permission required to name the person. If permission cannot be obtained, the journal can advise on an anonymized group acknowledgment or other handling.

Authorship changes

Adding, removing, or reordering authors after submission requires a truthful explanation and the confirmations required by the journal. If the group disputes contribution, pause and refer the matter to the relevant institution or governance process rather than trading authorship for agreement.

Important

In scenarios, test all four criteria and ask whether the contributor received a fair opportunity to meet them. Do not use job title, employer, compensation, enrollment count, or byline position as a shortcut.